Recursion Pharmaceuticals
pipeline partnerships guidance on top line for program guidance on interim safety for program guidance on trial update on program guidance on trial start update on collaboration including state of partnered pipeline update on collaboration platform target disclosure for project gamma announcement of and releases strong in cash and cash equivalents at the end of with potential for increased revenue in the near term new today | Recursion Pharmaceuticals
Company
Deck Type
Sector
Industry
Deck date
January 2023
Slide
18 of 143
Related slides by other companies
Genprex
Investor Presentation
October 2022
diabetes program | Genprex
argenx SE
Results
July 2021
our pipeline starts with our immunology innovation program | argenx SE
Inovalon
Mergers and Acquisitions
March 2018
guidance update | Inovalon
DICE Therapeutics
Investor Presentation
March 2023
| DICE Therapeutics
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io